PR Newswire Clinical TrialsOriginal article
New Study Shows That TissueCypher® Changed Management at an Expert Surgery Center in 90% of Patients With Non-Dysplastic Barrett's Esophagus
Data ReadoutpositiveTissueCypher® Barrett's Esophagus TestPositive
AI Analysis
Summary
Castle Biosciences announced publication of a study demonstrating that its TissueCypher Barrett's Esophagus Test changed patient management in 90% of patients with non-dysplastic Barrett's esophagus at an expert surgery center.
Outcome Details
Study showed TissueCypher test changed management in 90% of patients with non-dysplastic Barrett's esophagus
Importance:5/10
Sentiment:
0.70
diagnostic testBarrett's esophagusstudy publicationclinical guidance
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on September 28, 2026 11:00 AM